SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (4676)7/1/1998 2:37:00 AM
From: billkirn   of 6136
 
I can't help believe Peter and the Agouron Team have the ability to select the best possible candidates and have assembled a great team to file and get drug approval through the FDA, fast.
It seems to me that the additional investment and commitment to the HIV front could mean the cancer front may not have as much potential.
With the sales force, the FDA approval team, Viracept, great new emerging drug candidates for the HIV front and potential cancer products, we are in good hands. The ride will be good and long term..
Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News